Tee Lim

754 citations

16 papers · 267 indexed · h-index 7

Impact in

Radiation top 10%
- Advanced Radiotherapy Techniques
Pulmonary and Respiratory Medicine
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research

Papers in ⓘ

Radiation 6
- Advanced Radiotherapy Techniques 6
Pulmonary and Respiratory Medicine 12
- Prostate Cancer Treatment and Research 9
- Prostate Cancer Diagnosis and Treatment 9

Co-authors: Mark Frydenberg (4 shared papers)Michael Jefford (2 shared papers)Madeleine King (2 shared papers)Henry H. Woo (3 shared papers)Gillian Duchesne (3 shared papers)Mark Sidhom (3 shared papers)Amelia Hyatt (2 shared papers)Carol Fraser‐Browne (3 shared papers)
Journals: Journal of Clinical Oncology (5 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)British Journal of Urology (2 papers)Heart Rhythm (1 paper)BMJ Open (1 paper)
Partner nations: Australia United States United Kingdom

In The Last Decade

Tee Lim

14 papers receiving 266 citations

Peers

Countries citing papers authored by Tee Lim

Since Specialization

Citations

This map shows the geographic impact of Tee Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tee Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tee Lim more than expected).

Fields of papers citing papers by Tee Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tee Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tee Lim. The network helps show where Tee Lim may publish in the future.

Co-authors

The 25 scholars most cited alongside Tee Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tee Lim Line = papers co-authored together Tee Lim links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	A P hase III trial to investigate the timing of radiotherapy for prostate cancer with high‐risk features: background and rationale of the Radiotherapy – Adjuvant Versus Early Salvage ( RAVES ) trial British Journal of Urology ·Maria Pearse, Carol Fraser‐Browne, Ian D. Davis, Gillian Duchesne, Richard Fisher, Mark Frydenberg, Annette Haworth, Chakiath Jose, David Joseph, Tee Lim, John Matthews, Jeremy Millar, Mark Sidhom, Nigel Spry, Colin Tang, Sandra Turner, Scott Williams, Kirsty Wiltshire, Henry H. Woo, Andrew Kneebone	2014	80
2	ProCare Trial: a phase II randomized controlled trial of shared care for follow‐up of men with prostate cancer British Journal of Urology ·Jon Emery, Michael Jefford, Madeleine King, Dickon Hayne, Andrew Martin, Juanita Doorey, Amelia Hyatt, Emily Habgood, Tee Lim, Cynthia Hawks, Marie Pirotta, Lyndal Trevena, Penelope Schofield	2016	61
3	Hypofractionated Accelerated Radiotherapy Using Concomitant Intensity-Modulated Radiotherapy Boost Technique for Localized High-Risk Prostate Cancer: Acute Toxicity Results International Journal of Radiation OncologyBiologyPhysics ·Tee Lim, Patrick C.F. Cheung, D.A. Loblaw, Gerard Morton, Katharina E. Sixel, Geordi Pang, Parminder S. Basran, Liying Zhang, R. Tirona, Ewa Szumacher, Cyril Danjoux, Richard Choo, Gillian Thomas	2008	30
4	A Phase III Multi-Centre Randomised Trial comparing adjuvant versus early salvage Radiotherapy following a Radical Prostatectomy: Results of the TROG 08.03 and ANZUP “RAVES” Trial International Journal of Radiation OncologyBiologyPhysics ·Andrew Kneebone, Carol Fraser‐Browne, Warwick Delprado, Gillian Duchesne, Richard Fisher, Mark Frydenberg, Annette Haworth, Alan Herschtal, David Joseph, Tee Lim, Jarad Martin, Jeremy Millar, Mark Sidhom, Nigel Spry, Colin Tang, Susan Turner, Scott Williams, K. Wiltshire, Henry H. Woo, Maria Pearse	2019	30
5	Protocol for the ProCare Trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancer BMJ Open ·Jon Emery, Juanita Doorey, Michael Jefford, Madeleine King, Marie Pirotta, Dickon Hayne, Andrew Martin, Lyndal Trevena, Tee Lim, Roger Constable, Cynthia Hawks, Amelia Hyatt, Akhlil Hamid, John Violet, Suki Gill, Mark Frydenberg, Penelope Schofield	2014	19
6	Megavoltage cone beam digital tomosynthesis (MV-CBDT) for image-guided radiotherapy: a clinical investigational system Physics in Medicine and Biology ·Geordi Pang, A Bani‐Hashemi, P Au, P. F. O’Brien, J. A. Rowlands, Gerard Morton, Tee Lim, Patrick Cheung, Andrew Loblaw	2008	18
7	Pulmonary sclerosing pneumocytoma (sclerosing haemangioma): Radical radiation therapy Journal of Medical Imaging and Radiation Oncology ·Russell WB Fayers, Tee Lim, Marek Havlat	2016	11
8	Short-course Total Lymphoid Irradiation for Refractory Cardiac Transplantation Rejection The Journal of Heart and Lung Transplantation ·Tee Lim, Gerry O’Driscoll, Jerry M Freund, Vicki Peterson, Helen Hayes, J. Heywood	2007	6
9	Comparison of low‐dose, half‐rotation, cone‐beam CT with electronic portal imaging device for registration of fiducial markers during prostate radiotherapy Journal of Applied Clinical Medical Physics ·Ngie Min Ung, Leonard Wee, S. Hackett, A Jones, Tee Lim, Christopher Stirling Harper	2013	5
10	Baseline disease characteristics of participants enrolled on ENZARAD (ANZUP1303) and DASL-HiCaP (ANZUP1801) trials of highly effective androgen receptor antagonists in high-risk localized or locally advanced prostate cancer (PCa). Journal of Clinical Oncology ·Tamim Niazi, Paul L. Nguyen, Scott Williams, Martin R. Stockler, Andrew Martin, Lisa G. Horvath, Hayley Thomas, Danka Sinikovic Zebic, Felicia Roncolato, Tee Lim, Chakiath Jose, Jarad Martin, Hans T. Chung, Annie Ébacher, Scott C. Morgan, Simon Hughes, Sean M. McBride, Paul Kelly, Ian D. Davis, Christopher J. Sweeney, (unknown)	2024	2
11	DASL-HiCaP: Darolutamide augments standard therapy for localized very high-risk cancer of the prostate (ANZUP1801)—A randomized phase 3, double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation. Journal of Clinical Oncology ·Tamim Niazi, Sean M. McBride, Scott Williams, Ian D. Davis, Martin R. Stockler, Andrew Martin, Karen Bracken, Felicia Roncolato, Lisa G. Horvath, Shomik Sengupta, Jarad Martin, Tee Lim, Simon Hughes, Ray McDermott, James W.F. Catto, Paul J. Kelly, Wendy R. Parulekar, Scott C. Morgan, Ricardo Rendon, Christopher Sweeney, (unknown)	2022	2
12	DASL-HiCaP: Darolutamide augments standard therapy for localized very high-risk cancer of the prostate (ANZUP1801). a randomized phase 3 double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation. Journal of Clinical Oncology ·Sean M. McBride, Tamim Niazi, Scott Williams, Ian D. Davis, Martin R. Stockler, Andrew Martin, Karen Bracken, Felicia Roncolato, Lisa G. Horvath, Shomik Sengupta, Jarad Martin, Tee Lim, Simon Hughes, Ray McDermott, James W.F. Catto, Paul J. Kelly, Wendy R. Parulekar, Scott C. Morgan, Ricardo Rendon, Christopher J. Sweeney, (unknown)	2022	1
13	What is optimal timing of post prostatectomy radiotherapy? Is adjuvant radiotherapy equivalent to early salvage radiotherapy? The “RAVES” phase III randomized clinical trial. Journal of Clinical Oncology ·Maria Pearse, Andrew Kneebone, Gillian Duchesne, Richard Fisher, Carol Fraser‐Browne, Mark Frydenberg, Annette Haworth, Chakiath Jose, David Joseph, Tee Lim, John Matthews, Jeremy Millar, Mark Sidhom, Nigel Spry, Colin Tang, Sandra Turner, Scott Williams, Kirsty Wiltshire, Henry H. Woo, Ian D. Davis	2012	1
14	DASL-HiCaP: A randomized, phase 3, double-blind trial of darolutamide with androgen-deprivation therapy and definitive or salvage radiation for localized very high-risk prostate cancer. Journal of Clinical Oncology ·Tamim Niazi, Sean M. McBride, Scott Williams, Ian D. Davis, Martin R. Stockler, Andrew Martin, Hans T. Chung, Felicia Roncolato, Annie Ébacher, Eric Khoo, Jarad Martin, Tee Lim, Simon Hughes, David Pryor, James W.F. Catto, Paul Kelly, Leily Gholam Rezaei, Scott C. Morgan, Ricardo Rendon, Christopher Sweeney, (unknown)	2023	1
15	LBA86 Randomised phase III trial of androgen deprivation therapy (ADT) with radiation therapy with or without enzalutamide for high risk, clinically localised prostate cancer: ENZARAD (ANZUP 1303) Annals of Oncology ·P.L. Nguyen, C. Sweeney, M.R. Stockler, Heidi Thomas, Blossom Mak, Aiqin Zhang, Tee Lim, Caroline José, J. Martin, Nitya Patanjali, David Pryor, Phuoc T. Tran, Stephen Mangar, Alina Mihai, M Beresford, F. Sedlmayer, Paul Kelly, Simon Hughes, I.D. Davis, Sophie Williams	2025	0
16	B-PO03-067 PACEMAKER EXIT-BLOCK AFTER RADIOABLATION FOR VT CAUSING INAPPROPRIATE ICD SHOCKS AND BRADYCARDIC ARREST Heart Rhythm ·Sohail Popal, Benjamin King, Tee Lim	2021	0

About Tee Lim

Tee Lim is a scholar working on Radiation, Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 16 papers that have together received 267 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (9 papers), Advanced Radiotherapy Techniques (6 papers), Cancer survivorship and care (2 papers), Global Cancer Incidence and Screening (2 papers), Cardiac electrophysiology and arrhythmias (1 paper), Cancer Treatment and Pharmacology (1 paper) and Medical Imaging Techniques and Applications (1 paper). The work is most often cited by research in Radiation (85 citations), Pulmonary and Respiratory Medicine (176 citations), Oncology (75 citations), Public Health, Environmental and Occupational Health (50 citations) and Statistics and Probability (12 citations). Tee Lim has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Mark Frydenberg, Michael Jefford, Madeleine King, Henry H. Woo, Gillian Duchesne, Mark Sidhom, Amelia Hyatt, Carol Fraser‐Browne, Nigel Spry and Jon Emery. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, British Journal of Urology, Heart Rhythm and BMJ Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact